Stock Events

Stock Events

VYNE Therapeutics (VYNE) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-2.82

-1.93

-1.04

-0.15

Details

Expected EPS

-0.24

Actual EPS

-0.15

Surprise EPS

0.09

Surprise Percent

+37.5%

Description

VYNE Therapeutics (VYNE) has reported earnings of -0.15 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.